About
Microbiome, Antibody Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyMicrobiome
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
4
As Collaborator
3
Total Enrollment
1,441
By Phase
NA: 3PHASE1: 2PHASE2: 2
By Status
COMPLETED: 3RECRUITING: 2WITHDRAWN: 1UNKNOWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06482450Collaborator
Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
NARecruiting
1,200 participants
Started: Jun 11, 2025 · Completed: Jun 30, 2026
NCT06235541Lead Sponsor
A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors
PHASE1Withdrawn
Started: Feb 29, 2024 · Completed: May 31, 2027
NCT05998447Lead Sponsor
GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
PHASE2Recruiting
148 participants
Started: Sep 18, 2023 · Completed: Oct 31, 2026
NCT05419362Lead Sponsor
GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer
PHASE2Unknown
42 participants
Started: Apr 7, 2022 · Completed: Dec 31, 2024
NCT05510791Collaborator
Impact of Nuun SPORT on Subjective Exercise Performance in Male and Female Runners
NACompleted
20 participants
Started: Jan 19, 2022 · Completed: May 10, 2022
Locations (1)
Headquarters
Suwon, Korea
Map
Loading map...